期刊文献+

右美托咪定2种给药方法对鼻内镜术全身麻醉苏醒的影响 被引量:3

Effects of Two Different Methods of Dexmedetomidine Administration on Revival from General Anesthesia in Patients Undergoing Nasal Endoscopic Surgery
在线阅读 下载PDF
导出
摘要 目的探讨鼻内镜术患者应用右美托咪定对全身麻醉苏醒的影响。方法将40例行鼻内镜术患者按随机数字表法分为2组:右美托咪定单次给药组(A组)、右美托咪定维持给药组(B组),每组20例。术毕送麻醉恢复室(PACU),观察并记录:入手术室基础值(T0)、拔管时(T1)、拔管后5 min(T2)不同时间点患者的血压、心率、脉氧饱和度;患者在PACU所发生的不良反应。结果 B组在拔管时、拔管后5 min血压和心率与A组相比降低(P<0.05),B组心动过缓和低血压发生率高于A组(P<0.05)。结论鼻内镜术患者应用右美托咪定宜单次给予诱导剂量,不宜维持给药。 Objective To evaluate the effects of two different methods of dexmedetomidine administration on revival from general anesthesia in patients undergoing nasal endoscopic surgery.Methods Forty patients undergoing nasal endoscopic surgery under general anesthesia were randomly assigned to receive either single dose dexmedetomidine administration(group A,n=20) or continuous dexmedetomidine administration(group B,n=20).All patients were delivered into postanesthesia care unit(PACU)after operation.The blood pressure(BP),heart rate(HR) and oxygen saturation(SpO2) were measured before operation(T0),at the time of extubation(T1)and 5 minutes after extubation(T2).The adverse events were recorded during PACU stay.Results Compared with group A,continuous dexmedetomidine administration significantly decreased BP and HR at T1 and T2,but obviously increased the incidence of bradycardia and hypotension(P〈0.05).Conclusion Dexmedetomidine should been medicated singly but not continuously in patients undergoing nasal endoscopic surgery.
出处 《实用临床医学(江西)》 CAS 2012年第7期28-30,共3页 Practical Clinical Medicine
基金 江西省科技厅科技计划(20111BBG70022-1)
关键词 右美托咪定 鼻内镜术 全身麻醉苏醒 dexmedetomidine nasal endoscopic surgery revival from general anesthesia
作者简介 喻剑萍(1979-),女,硕士,主治医师,主要从事临床麻醉学的研究。
  • 相关文献

参考文献9

  • 1李民,张利萍,吴新民.右美托咪啶在临床麻醉中应用的研究进展[J].中国临床药理学杂志,2007,23(6):466-470. 被引量:484
  • 2袁宏勋,顾科,王保国.静脉输注右美托嘧啶抑制芬太尼引起的呛咳[J].中国病案,2011,12(5):63-64. 被引量:11
  • 3Chu K S.Wang R Y,Hsu H T,et al.The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreop tic nasal intubation [J].European Journal of Anaesthesiology,2010,27 ( 1 ):36-40.
  • 4Shukry M,Miller J A. Update on dexmedetomidine:use in nonintubated patients requiring sedation for surgical procedures[J].Ther Clin Risk Manag,2010,15(6):111-121.
  • 5Ghali A, Mahfouz A K, Ihanamaki T, et al.Dexmedetomidine versus propofol for sedation in patients undergoing vitreoretinal surgery under sub-Tenon' s anesthesia [J]. Saudi J Anaesth,2011,5( 1 ):36-41.
  • 6梁飞,肖晓山.盐酸右美托咪定的临床药理及应用[J].现代医院,2010,10(5):90-93. 被引量:126
  • 7Del Angel Garcia R,Castellanos Olivares A,Munguia Miranda C.Dexmedetomidine as preventive postoperative analgesia in inguinal hernioplasty [J].Gac Med Mex,2006, 142(1):9-12.
  • 8Nelson L E,Lu J,Guo T Z,et al. The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J]. Anesthesiology,2003,98:428-436.
  • 9McVey J D,Tobias J D. Dexmedetomidine and ketamine for sedation during spinal anesthesia in children [J].Clin Anesth, 2010,22 (7) :538-545.

二级参考文献91

  • 1[1]Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists:their pharmacology and therapeutic role[J].Anesthesia,1999;54:146-165.
  • 2[2]Kamibayashi T,Maze M.Clinical uses of alpha 2-adrenergic agonists[J].Anesthesiology,2000;93:1345-1350.
  • 3[3]Calzada BC,De Artinano AA.[alpha]2-Adrenoreceptor subtypes[J].Pharmacol Res,2001;44:195-208.
  • 4[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
  • 5[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
  • 6[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
  • 7[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
  • 8[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.
  • 9[9]Ebert TJ,Hall JE,Barney JA,et al.The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000;93:382-394.
  • 10[10]Ramsey MA,Luterman DL.Dexmedetomidine as a total intravenous anesthestic agent[J].Anesthesiology,2004;101:787-781.

共引文献595

同被引文献29

  • 1Basar H,Akpinar S,Doganci N,et al.The effects of preanesthetic,single-dose dexmedetomidine on induction,hemodynamic,and cardiovascular parameters[J].J Clin Anesth,2008,20(6):431-436.
  • 2Shukla D,Verma A,Agarwal A,et al.Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to bupivacaine[J].J Anaesthesiol Clin Pharmacol,2011,27(4):495-499.
  • 3Su F,Hammer GB.Dexmedetomidine:pediatric pharmacology,clinical uses and safety[J].Expert Opin Drug Saf,2011,10(1):55-66.
  • 4Boyd BC,Sutter SJ.Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections[J].J Oral Maxillofac Surg,2011,69(6):1608-1612.
  • 5Berridge CW,Schmeichel BE,Espana RA.Noradrenergic modulation of wakefulness/arousal[J].Sleep Med Rev,2012,16(2):187-197.
  • 6El-Hennawy AM,Abd-Elwahab AM,Abd-Elmaksoud AM,et al.Addition of clonidine or dexmedetomidine to bupivacaine prolongs caudal analgesia in children[J].Br J Anaesth,2009,103(2):268-274.
  • 7Kawaai H,Satoh J,Watanabe M,et al.A Comparison of intravenous sedation with two does of dexmedetomidine:0.2μg/kg/hr verus0.4μg/kg/hr[J].Anesth Prog,2012,57(3):96.
  • 8Patel A,Davidson M,Tran MC,et al.Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing Tonsill-ectomy and adenoidectomy[J].Anesth Analg,2010,111(4):1004-1010.
  • 9Tasdogan M,Memis D,Sut N,et al.Results of a pilot study on the effects of propofol and dex-medetomidine on inflammatory responses and intraabdominal pressure in severe sepsis[J].J Clin Anesth,2009,21(6):394-400.
  • 10Schoeler M,Loetscher PD,Rossaint R,et al.Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury[J].BMC Neurol,2012,12(1):20..

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部